Value of UGT2B7-161 Single Nucleotide Polymorphism in Predicting the Risk of Cardiotoxicity in HER-2 Positive Breast Cancer Patients Who Underwent Pertuzumab Combined with Trastuzumab Therapy by PSL.
Pharmgenomics Pers Med
; 15: 215-225, 2022.
Article
em En
| MEDLINE
| ID: mdl-35321089
Texto completo:
1
Bases de dados:
MEDLINE
Tipo de estudo:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Pharmgenomics Pers Med
Ano de publicação:
2022
Tipo de documento:
Article